Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
6
×
clinical trials
6
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
merck
6
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
eli lilly
bristol-myers squibb
cancer immunotherapy
fda
moderna
pfizer
startups
abbvie
alzheimer's disease
deals
What
bio
6
×
roundup
companies
drug
growing
life
nash
new
news
science
week
advantages
alliance
approval
approved
arena’s
bar
biogen’s
biopharmaceutical
black
bounty
brings
bristol
buy
calls
changing
cig
color
comeback
continue
convo
corner
crispr
days
deals
debut
delivered
diamond
diamond’s
digital
Language
unset
Current search:
cancer
×
bio
×
" clinical trials "
×
merck
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More